Coronary disease & ACS

Paired risk scores to predict ischaemic and bleeding risk twenty-eight days to one year after an acute coronary syndrome

HeartPublished Risk prediction model development study

Authors' conclusion

We present a pair of ischaemic and bleeding risk scores specifically to assist clinicians and their patients in deciding on DAPT duration beyond the first month post-ACS.

Study context

Population
New Zealand (NZ) patients aged 18–84 years with acute coronary syndrome (ACS) investigated with coronary angiography (2012–2020), event free at 28 days postdischarge, without AF
Participants
27,755 patients
Exposure
Ischaemic score vs Bleeding score
Outcome
Ischaemic events (CV mortality/rehospitalisation with MI or ischaemic stroke) and major bleeding events (bleeding mortality/rehospitalisation with bleeding)
Follow-up
28 days to 1 year postdischarge
Methodological detailsregistry cohort, registry-based, linked national health datasets
  • Registry cohort
  • Registry-based
  • Linked national health datasets

Main finding

As reported in the abstract

Discrimination of the 28-day to 1-year risk scores (Harrell's c-statistic)

Ischaemic events

1200

4.3%

Major bleeding events

548

2.0%

Observational data: associations, not effects.

Further findings

Risk categories applying the scores to the 2020 ESC ACS antithrombotic algorithm

Elevated (>2%) bleeding and ischaemic risk: abbreviated DAPT considered
31%
Low bleeding, elevated ischaemic risk: prolonged DAPT may be appropriate
37%
Low bleeding and ischaemic risk: short DAPT may be justified
29%

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Paired risk scores to predict ischaemic and bleeding risk twenty-eight days to one year after an acute coronary syndrome. Heart. Published 9 August 2023. doi:10.1136/heartjnl-2023-322830

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.